Please use this identifier to cite or link to this item:
|Title:||One step forward: The use of transgenic zebrafish tumor model in drug screens||Authors:||Huang, X.
|Issue Date:||Jun-2011||Citation:||Huang, X., Nguyen, A.T., Li, Z., Emelyanov, A., Parinov, S., Gong, Z. (2011-06). One step forward: The use of transgenic zebrafish tumor model in drug screens. Birth Defects Research Part C - Embryo Today: Reviews 93 (2) : 173-181. ScholarBank@NUS Repository. https://doi.org/10.1002/bdrc.20208||Abstract:||The zebrafish (Danio rerio) has been an experimental model in the developmental biology and toxicology since the 1950s. In recent years, with the aid of transgenic technology, it has also gained an increasing popularity to model human diseases, including various cancers. As a feasible vertebrate model for large-scale chemical screens, the zebrafish has also given us a new option for the search of potential anticancer drugs. It is hopeful that in the near future with automation and analytical tools, drug development processes will be significantly shortened for quick and effective identification of candidate drugs. © 2011 Wiley-Liss, Inc.||Source Title:||Birth Defects Research Part C - Embryo Today: Reviews||URI:||http://scholarbank.nus.edu.sg/handle/10635/102507||ISSN:||1542975X||DOI:||10.1002/bdrc.20208|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jun 17, 2019
WEB OF SCIENCETM
checked on Jun 10, 2019
checked on Jun 14, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.